Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term InvestmentsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsSecuritiesSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MetroCity Bankshares (MCBS) Cash & Equivalents (2018 - 2025)

MetroCity Bankshares (MCBS) has disclosed Cash & Equivalents for 8 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 97.52% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, down 97.52% year-over-year, with the annual reading at $6.2 million for FY2025, 97.52% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $6.2 million at MetroCity Bankshares, down from $9.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $424.7 million in Q1 2022, with the low at $6.2 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $218.0 million, with a median of $251.6 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 143.79% in 2022, then crashed 97.52% in 2025.
  • Over 5 years, Cash & Equivalents stood at $253.3 million in 2021, then decreased by 29.04% to $179.7 million in 2022, then decreased by 19.43% to $144.8 million in 2023, then surged by 72.56% to $249.9 million in 2024, then plummeted by 97.52% to $6.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $6.2 million, $9.4 million, and $13.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.